Medicines Marketed by Hindustan Antibiotics Limited

About Hindustan Antibiotics Limited

Hindustan Antibiotics Limited (HAL) is a pioneering public sector undertaking in the pharmaceutical industry, established on March 10, 1954, with the active cooperation of the World Health Organization (WHO) and UNICEF. As the first medication manufacturing company set up by the Government of India, HAL has played a significant role in the country's pharmaceutical sector for over 70 years.

Based in Pimpri, an industrial suburb of Pune, Maharashtra, India, HAL's primary operations are centred in India. The company's products cater to both domestic and international markets, although its consumer base is predominantly localised within India. HAL is diversified in the formulation and manufacture of various pharmaceutical products, including injectables, capsules, tablets, large volume parenterals, liquid orals, and agro-vet products.

Hindustan Antibiotics Limited Products

Hindustan Antibiotics Limited is a versatile manufacturer of a wide array of pharmaceutical and agro-vet products. The company's most popular products include antibiotics such as Penicillin, Streptomycin, Gentamicin, Ampicillin, and Amoxycillin, which were among the first to be commercially produced in India by HAL. Other notable products include Diclofenac Sodium & Paracetamol for pain relief and anti-inflammatory purposes, Phenoxy Methylpenicillin Potassium, Tetracycline 250 mg, Cephalexin, Erythromycin Stearate, and Streptomycin Sulphate.

HAL's products adhere to international standards, with a strong emphasis on stability, bioavailability studies, in-process control, and quality assurance, ensuring high-quality products. The company's R&D department has made significant contributions, including the discovery of Hamycin for skin infections and Aureofungin Sol for plant fungal control, which are unique to HAL. With a commitment to providing affordable medications across India, HAL aligns with its social objective and contributes to public health.